Inovio Pharmaceuticals Latest News
- 03-14 AInvest NewsInovio Pharmaceuticals: Citizens Capital Markets reiterates the 'Market Outperform' Rating, The Target Price is $18
- 03-14 AInvest WireCitizens Capital Markets Raises PT to $18 for Inovio Pharmaceuticals
- 03-13 AInvest ExclusiveINOVIO's DNA-Encoded Antibodies: A Game Changer for COVID-19 and Beyond?
- 03-12 AInvest WireINOVIO Announces Q4 and Year-End 2024 Financial Results for March 18, 2025
- 03-12 AInvest WireInovio Pharmaceuticals shares rise 1.03% intraday as certain stock options are subject to a lock-up agreement ending on 12-MAR-2025.
- 02-28 AInvest NewsInsider Transactions Reported | Inovio Pharmaceuticals(INO)saw insider trading activity on 2/28/2025
- 02-28 AInvest WireInovio Pharmaceuticals Expected to Post Loss of 84 Cents a Share in Q4 2024
- 02-26 AInvest WireINEO Announces Insider and Arm's Length Party Shares Acquisition
- 02-14 AInvest WireInnovative's 15-Minute Chart Sees KDJ Death Cross, Bearish Marubozu Pattern
- 02-12 AInvest WireInovio Pharmaceuticals CEO Jacqui Shea Discusses Lead Program INO-3107 and Planned BLA Submission
- 02-12 AInvest WireBottom Fishing Opportunity: Inovio Pharmaceuticals (INO)
- 02-12 NasdaqHere's Why Inovio (INO) Could be Great Choice for a Bottom Fisher
- 02-12 AInvest WireInovio's Respiratory DNA Drug Shows Promising Results in Early Trial
- 02-12 AInvest WireINO-3107 trial data shows T-cell response and reduced surgeries for RRP.
- 02-12 MarketWatchInovio announces peer-reviewed data from phase 1/2 clinical trial with INO-307
- 02-11 AInvest WireInovio Pharmaceuticals shares fall 2.34% intraday after pricing $36M offering.
- 02-10 AInvest WireInovio Pharmaceuticals shares fall 5.61% intraday after pricing $36M offering.
- 02-10 AInvest WireINO-3107 Shows Positive Immunological Activity in AACR-IO Poster Presentation
- 02-10 AInvest WireINO-3107 shows promising results in treating Recurrent Respiratory Papillomatosis.
- 02-06 AInvest WireInovio Pharmaceuticals shares fall 1.47% intraday after CEO presentation.
Show More News